Pearls and Prep · Mar 20, 2026 · 19:09
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”
Be the second on Patreon:
👉 https://www.patreon.com/PearlsandPrep
Board Bombs - Back by popular demand!
This episode delves into the intricacies of psychopharmacology, specifically focusing on the management of antipsychotic medications and mood stabilizers. We engage in a thorough examination of high-yield questions pertinent to psychiatric nurse practitioners, with a particular emphasis on the clinical implications of medication side effects. The discourse elucidates the importance of recognizing the potential metabolic consequences of antipsychotic treatments, particularly in patients with significant mental health disorders. Furthermore, we explore the pharmacological nuances that guide the selection of appropriate antidepressants, especially in the context of coexisting chronic pain disorders. Our aim is to enhance clinical acumen and preparedness for upcoming psychiatry board examinations through this rigorous analysis.
27
Board Bombs: Can you get these 3, high-yield board-style questions right today?
Pearls and Prep
pearlsandprep@mail.com
https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink
The discussion centers around the intricate and multifaceted realm of psychopharmacology, specifically addressing the pivotal role of antipsychotic medications in the management of schizophrenia. A particular case is presented, wherein a mock patient, 28-year-old female patient exhibits significant distress from the side effects of Risperdal, a medication she has been stable on for six months. The episode delves into the clinical implications of managing antipsychotic-induced hyperprolactinemia, as evidenced by her elevated prolactin levels and the associated symptoms of breast tenderness and menstrual irregularities. The discourse emphasizes the necessity of a nuanced understanding of the medication's side effects and the importance of maintaining stability in patients with serious mental illnesses. Various treatment options are scrutinized, leading to the conclusion that switching to Abilify, a metabolically favorable alternative, would be the most judicious course of action, thereby mitigating both the side effects while preserving therapeutic efficacy against psychosis.
Takeaways:
Companies mentioned in this episode: